von Willebrand factor clearance does not involve proteolysis by ADAMTS-13

被引：16
作者：
Badirou, I. [1 ]
Kurdi, M. [1 ]
Rayes, J. [1 ]
Legendre, P. [1 ,2 ]
Christophe, O. D. [1 ,2 ]
Lenting, P. J. [1 ,2 ]
Denis, C. V. [1 ,2 ]
机构：
[1] INSERM, U770, F-94276 Le Kremlin Bicetre, France
[2] Univ Paris Sud, UMR 770, F-94275 Le Kremlin Bicetre, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 10期
关键词：
SURVIVAL; MUTATION; MODEL;
D O I：
10.1111/j.1538-7836.2010.04012.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2338 / 2340
页数：3
相关论文
共 9 条
  • [1] Bowen DJ, 2003, THROMB HAEMOSTASIS, V90, P961
  • [2] Systemic antithrombotic effects of ADAMTS13
    Chauhan, AK
    Motto, DG
    Lamb, CB
    Bergmeier, W
    Dockal, M
    Plaimauer, B
    Scheiflinger, F
    Ginsburg, D
    Wagner, DD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) : 767 - 776
  • [3] ADAMTS13: a new link between thrombosis and inflammation
    Chauhan, Anil K.
    Kisucka, Janka
    Brill, Alexander
    Walsh, Meghan T.
    Scheiflinger, Friedrich
    Wagner, Denisa D.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (09) : 2065 - 2074
  • [4] Clearance of von Willebrand factor
    Denis, Cecile V.
    Christophe, Olivier D.
    Oortwijn, Beatrijs D.
    Lenting, Peter J.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 271 - 278
  • [5] An experimental model to study the in vivo survival of von Willebrand factor -: Basic aspects and application to the R1205H mutation
    Lenting, PJ
    Westein, E
    Terraube, V
    Ribba, AS
    Huizinga, EG
    Meyer, D
    de Groot, PG
    Denis, CV
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12102 - 12109
  • [6] Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations
    Millar, Carolyn M.
    Riddell, Anne F.
    Brown, Simon A.
    Starke, Richard
    Mackie, Ian
    Bowen, Derrick J.
    Jenkins, P. Vincent
    van Mourik, Jan A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 916 - 924
  • [7] Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice
    Motto, DG
    Chauhan, AK
    Zhu, GJ
    Homeister, J
    Lamb, CB
    Desch, KC
    Zhang, WR
    Tsai, HM
    Wagner, DD
    Ginsburg, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) : 2752 - 2761
  • [8] Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B
    Rayes, Julie
    Hollestelle, Martine J.
    Legendre, Paulette
    Marx, Isabelle
    de Groot, Philip G.
    Christophe, Olivier D.
    Lenting, Peter J.
    Denis, Cecile V.
    [J]. BLOOD, 2010, 115 (23) : 4870 - 4877
  • [9] Stoddart JH, 1996, BLOOD, V88, P1692
1